PRE-CONFERENCE WORKSHOP DAY LIVE
Tuesday, February 27, 2024
Workshop A 10.00 – 11.00
Enhancing Clinical Outcomes & Success Rates: Optimizing Bacteriophage Drug Development Platforms
Synopsis
With heightened momentum in bacteriophage therapy, the industry is anticipating substantial updates in clinical results, which will be the defining moment for facing antimicrobial resistance. However, this is easier said than done, given the complexity of clinical trial design, regulatory requirements, and patient recruitment. We will utilize this interactive workshop to give you hands-on guidance on designing and preparing a platform to develop an efficacious phage drug that supports pipeline progression and enhance clinical outcomes.
Join this 1-hour session and learn how to:
- Integrate technologies and strategies to identify phage for better selection of phage cocktails
- Combine in vitro, in vivo, and eIND data to facilitate clinical translatability for pipeline development
- Construct ‘artificial patient’ models in lab to discover rare phage for improved patient outcomes
Workshop B 1.00 – 4.00
Tailored Fundraising & Business Model for Bacteriophage Therapy Development & Commercial Viability
Synopsis
Bacteriophage therapy has lucrative potentials, but funding, market access, and sustainable profitability will require a new playbook compared to traditional drug development approaches.
Join this 3-hour session and learn how to:
- Identify funding opportunities that are personalized for your business at early-stage phage therapy development
- Secure adequate funding for R&D and commercialization of clinical trial outcomes to advance phage therapy approval
- Define executable market access strategies and establish collaborations to drive phage therapy opportunities forward